Banco de Sabadell’s Quest Diagnostics DGX Stock Holding History

Banco de Sabadell’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,698	Closed	-$1.07M	–	414
2018 Q1	$1.07M	Buy	+10,698	New	+$1.1M	0.13%	175

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Banco de Sabadell's DGX Position: Q2 2018 in Review

Banco de Sabadell sold out of Quest Diagnostics (DGX) in Q2 2018, closing a stake of 10,698 shares — an estimated $1.07M sold.

Banco de Sabadell first reported a position in DGX in Q1 2018 and held it in 1 quarter. The position peaked at $1.07M in Q1 2018. 662 funds tracked by Wall St. Rank hold DGX as of Q2 2018.

Banco de Sabadell reported no remaining Quest Diagnostics position as of Q2 2018 after selling out during the quarter.
Banco de Sabadell sold 10,698 Quest Diagnostics shares in Q2 2018, an estimated $1.07M.
Banco de Sabadell first reported a position in Quest Diagnostics in Q1 2018 and held it in 1 quarter.
Banco de Sabadell's Quest Diagnostics position peaked at $1.07M in Q1 2018.
662 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2018.

Based on Banco de Sabadell's 13F filing for Q2 2018, filed 15 Aug 2018.